Company Overview of InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc., a product-focused cardiovascular company, develops transformative therapies for patients to use in the first moments of acute cardiovascular symptoms. It develops an inhaled therapy to treat Paroxysmal atrial fibrillation. The company was formerly known as Pleiades Cardio-Therapeutics, Inc. InCarda Therapeutics, Inc. was incorporated in 2009 and is based in Palo Alto, California.
228 Hamilton Avenue
Palo Alto, CA 94301
Founded in 2009
Key Executives for InCarda Therapeutics, Inc.
Similar Private Companies By Industry
|Ethos Pharmaceuticals, Inc.||United States|
|McNEIL-PPC, Inc.||United States|
|DiaKine Therapeutics, Inc.||United States|
|Searle & Co.||United States|
|Glycomed Incorporated||United States|
Recent Private Companies Transactions
September 3, 2013
To contact InCarda Therapeutics, Inc., please visit incardatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.